Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2009-011246-25 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neramexane mesylate | Experimental | Double-blind treatment period of 29 weeks up to 75 mg Neramexane mesylate per day |
|
| Placebo | Placebo Comparator | Placebo: identical placebo tablets |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neramexane mesylate | Drug | Double-blind treatment period of 29 weeks up to 75 mg Neramexane mesylate per day |
|
| Measure | Description | Time Frame |
|---|---|---|
| Absolute Change in TBF-12 (Tinnitus Handicap Inventory-12) Total Score from Baseline. | The TBF-12 is an adapted German version of the original English THI (Tinnitus Handicap Inventory). It is a self-report questionnaire assessing 12 items from 2 dimensions: emotional-cognitive factors and functional-communicational factors. Each item is rated with 0-2 (2= "often"; 1= "sometimes"; 0= "never"). The maximum score is 24 indicating most severe tinnitus impairment. Hierarchical test procedure: Step 1: week 29 in subjects reporting acute hearing loss; step 2: week 17, ditto; step 3: week 29 in total population; step 4: week 17, ditto. | Baseline to week 17 and 29 |
| Absolute Change in TSSw (Tinnitus Severity Scale - One Week Version) Total Score from Baseline. | The TSSw is a measure of tinnitus severity. It will be self-evaluated by the patient at various time points on an 11-point Likert-like scale asking for the past week. The scores range from 0 (indicating no tinnitus) to the maximum score of 10 (characterizing the most severe tinnitus considered). Hierarchical test procedure: Step 1: week 29 in subjects reporting acute hearing loss; step 2: week 17, ditto; step 3: week 29 in total population; step 4: week 17, ditto. | Baseline to week 17 and 29 |
| Measure | Description | Time Frame |
|---|---|---|
| TBF-12 Total Score: Change from Baseline | See outcome measure #1. | Baseline to week 5, 17, 23, and 29 |
| TBF-12 Factorial Scores: Change from Baseline | See outcome measure #1. |
Not provided
Main Inclusion Criteria:
Main Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Expert | Merz Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Horizon Clinical Research Associates PLLC | Gilbert | Arizona | 85295 | United States | ||
| Phoenix Clinical |
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Double-blind treatment period of 29 weeks placebo |
|
| Baseline to week 5, 17, 23, and 29 |
| TBF-12: Individual Responder Rate | See outcome measure #1. A subject is considered responder if TBF-12 decreases at least 4 score points between baseline and respective visit. | Week 5, 17, 23, and 29 |
| Tinnitus Rating Scale (one week version): Change from Baseline | Tinnitus Rating Scale is a self-evaluated 11-point Likert scale assessing tinnitus loudness, annoyance, and impact on life. The scores range from 0 (no impact), to the maximum score of 10 (worst influence of the problem considered). Single scores and sum scores will be analysed. | Baseline to week 5, 17, 23, and 29 |
| Tinnitus Severity Scale (one week version): Change from Baseline | See outcome measure #2. | Baseline to week 5, 17, 23, and 29 |
| Attention and Performance Self-Assessment (ASPA) Questionnaire: Change from Baseline | The ASPA consists of 30 simple statements for which the patient can determine how regular this happens to him/her. The response options for each statement are "never", "seldom", "sometimes", "often" and "always". | Baseline to week 5, 17, 23, and 29 |
| Quality of Life Questionnaire (SF-36™ Health Survey): Change from Baseline | The SF-36 is a multipurpose health survey with 36 questions. It is a generic measure commonly used in general and specific populations, comparing the relative burden of diseases, and in differentiating the health benefits produced by a wide range of different treatments. | Baseline to week 17 and 29 |
| Hospital Anxiety and Depression Scale (HADS): Change from Baseline | The HADS is a self-assessment scale with 14 items which has been developed for non psychiatrists to detect states of depression and anxiety in a hospital outpatient population. Every item is rated with a scale (3= very often indeed; 2= quite often; 1= not very often; 0= not at all). Lower total scores indicate "normal", higher total scores "abnormal". | Baseline to week 17 and 29 |
| Phoenix |
| Arizona |
| 85015 |
| United States |
| Paradigm Clinical Research | Tucson | Arizona | 85705 | United States |
| Providence Clinical Research | Burbank | California | 91505 | United States |
| Central California Clinical Research | Fresno | California | 93720 | United States |
| UC Davis Health System | Sacramento | California | 95817 | United States |
| Colorado Otolaryngology Associates | Colorado Springs | Colorado | 80909 | United States |
| New West Physicians | Golden | Colorado | 80401 | United States |
| Visions Clinical Research | Boynton Beach | Florida | 33472 | United States |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | United States |
| Clinical Research of West Florida, Inc. | Tampa | Florida | 33603 | United States |
| Deerpath Physicians Group | Gurnee | Illinois | 60031 | United States |
| Knight Center for Integrated Health | Peoria | Illinois | 61614 | United States |
| Deaconess Clinic, Inc. | Evansville | Indiana | 47710 | United States |
| MediSphere Medical Research Center, LLC | Evansville | Indiana | 47714 | United States |
| Deaconess Clinic, Inc. | Newburgh | Indiana | 47630 | United States |
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242-1078 | United States |
| University of Kansas; Department of Otolaryngology Head & Neck Surgery | Kansas City | Kansas | 66160-0001 | United States |
| Heartland Research Associates, LLC. | Wichita | Kansas | 67205 | United States |
| Heartland Research Associates, LLC. | Wichita | Kansas | 67207 | United States |
| Commonwealth Ear, Nose & Throat | Louisville | Kentucky | 40207 | United States |
| Glacier Ear, Nose, and Throat, Head and Neck Surgery, P.C. | Kalispell | Montana | 59901 | United States |
| Immedicenter | Bloomfield | New Jersey | 07003 | United States |
| David L. Bortniker | Somerville | New Jersey | 08876 | United States |
| Erie County Medical Center, Department of Rehabilitation Medicine; State University of New York at Buffalo | Buffalo | New York | 14221 | United States |
| Montefiore Medical Center | The Bronx | New York | 10867 | United States |
| Cary Medical Research | Cary | North Carolina | 27518 | United States |
| Wake Research Associates, LLC | Raleigh | North Carolina | 27612 | United States |
| Wilmington Medical Research | Wilmington | North Carolina | 28401 | United States |
| Piedmont Medical Research | Winston-Salem | North Carolina | 27103 | United States |
| Medical University of South Carlolina, Otolaryngology | Charleston | South Carolina | 29425 | United States |
| Austin Ear, Nose and Throat Clinic | Austin | Texas | 78705 | United States |
| Future Search Trials of Neurology | Austin | Texas | 78756 | United States |
| FutureSearch Trials of Dallas | Dallas | Texas | 75231 | United States |
| R/D Clinical Research, Inc. | Lake Jackson | Texas | 77566 | United States |
| South Texas Research Alliance LLC | Laredo | Texas | 78041 | United States |
| Research Across America | Plano | Texas | 75093 | United States |
| Advanced Clinical Research | West Jordon | Utah | 84088 | United States |
| Health Research of Hampton Roads, Inc. | Newport News | Virginia | 23606 | United States |
| Krankenhaus der Elisabethinen | Graz | 8020 | Austria |
| Bezirkskrankenhaus Kufstein | Kufstein | 6330 | Austria |
| A. ö. Krankenhaus der Elisabethinen Linz | Linz | 4010 | Austria |
| Clin Pharm International GmbH, Zentrum Wien | Vienna | 1090 | Austria |
| Consultório Dr. Marcelo Rates | Belo Horizonte | 30150-270 | Brazil |
| Instituto de Otorrinolaringologia Linhares | Rio de Janeiro | Brazil |
| Hospital de Clinicas de Porto Alegre | Rio Grande | 90035-001 | Brazil |
| Faculdade de Medicina do ABC | Santo André/SP | Brazil |
| Universidade Federal de São Paulo - UNIFESP | Sao Paulo/ SP | Brazil |
| Instituto Ganz Sanchez | São Paulo/SP | 05469-000 | Brazil |
| Clínica OTOSUL | Valença | Brazil |
| Klin. Forschung Berlin Buch GmbH | Berlin | 13125 | Germany |
| Praxis im Schlosscarree | Braunschweig | 38100 | Germany |
| Dr. Klaus Peter Jayme | Darmstadt | 64283 | Germany |
| Dr. Christian Dörr | Dresden | 01277 | Germany |
| Dr. Elisabeth Kühne | Halle | 06112 | Germany |
| Dr. Werner Gieselmann | Heiligenhaus | 42579 | Germany |
| Dr. Wolfgang Lotte | Iserlohn | 58642 | Germany |
| ClinPharm International GmbH | Leipzig | 04103 | Germany |
| HNO Praxis, Bamberger Str. 7 | Lichtenfels | 96215 | Germany |
| Dr. Dannesberger | Lorsch | 64653 | Germany |
| LMU München, Klinikum Großhadern | München | 81377 | Germany |
| Dr. Susanne Wiedemann | Nuremberg | 90443 | Germany |
| Instituto Biomédico de Investigación A.C. | Aguascalientes | CP 20127 | Mexico |
| Hospital General de Chihuahua | Chihuahua City | C.P. 31000 | Mexico |
| Hospital Christus Muguerza del Parque | Chihuahua City | CP 3100 | Mexico |
| Clinical Research Instutute S.C. | Edo. de México | CP 54055 | Mexico |
| Hospital Civil de Guadalajara "Fray Antonio Alcalde", Servicio de Otorrinolaringología; Hospital No. 278 | Guadalajara Jalisco | CP 44280 | Mexico |
| Grupo Médico Terranova | Guadalajara Jalisco | CP 44630 | Mexico |
| Unidad de Investigación Clínica Cardiometábolica de Occidente S.C. (UNICAMO) | Jalisco | 44150 | Mexico |
| Hospital General de México S.S. O.D.; Servicio de Otorrinolaringología | México D.F. | 06726 | Mexico |
| Hospital OCA Monterrey International Research Center (MIRC) | Nuevo León | CP 64000 | Mexico |
| Hospital Universitario | Nuevo León | CP 64400 | Mexico |
| Unidad de Tratamientos Avanzados (UTRAV) S.C. | Nuevo León | CP64240 | Mexico |
| Hospital Central "Dr. Ignacio Morones Prieto"; Servicio de Otorrinolaringología | San Luis Potosí City | 78240 | Mexico |
| Medicentro del Parque | San Luis Potosí City | C.P. 78269 | Mexico |
| Unidad Médica de Especialidades del Noroeste (UMEN) | Sinaloa | 80000 | Mexico |
| ID | Term |
|---|---|
| D014012 | Tinnitus |
| ID | Term |
|---|---|
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided